Icecure Medical EBITDA vs. Current Valuation

ICCM Stock  USD 0.94  0.10  11.90%   
Taking into consideration Icecure Medical's profitability measurements, Icecure Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Icecure Medical's ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-15.3 M
Current Value
-14.5 M
Quarterly Volatility
4.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Icecure Medical's Days Sales Outstanding is very stable compared to the past year. As of the 12th of December 2024, Sales General And Administrative To Revenue is likely to grow to 1.56, while EV To Sales is likely to drop 11.44. At this time, Icecure Medical's Total Other Income Expense Net is very stable compared to the past year. As of the 12th of December 2024, Income Tax Expense is likely to grow to about 162.9 K, though Operating Income is likely to grow to (14.8 M).
For Icecure Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Icecure Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Icecure Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Icecure Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Icecure Medical over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
0.071
Quarterly Revenue Growth
0.079
Return On Assets
(0.47)
Return On Equity
(0.94)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Icecure Medical Current Valuation vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Icecure Medical's current stock value. Our valuation model uses many indicators to compare Icecure Medical value to that of its competitors to determine the firm's financial worth.
Icecure Medical is rated below average in ebitda category among its peers. It is rated below average in current valuation category among its peers . Icecure Medical reported last year EBITDA of (15.25 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Icecure Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Icecure Current Valuation vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Icecure Medical

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(15.25 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Icecure Medical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
36.16 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Icecure Current Valuation vs Competition

Icecure Medical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 13.4 Billion. Icecure Medical adds roughly 36.16 Million in current valuation claiming only tiny portion of equities under Health Care industry.

Icecure Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Icecure Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Icecure Medical will eventually generate negative long term returns. The profitability progress is the general direction of Icecure Medical's change in net profit over the period of time. It can combine multiple indicators of Icecure Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income3.1 M2.7 M
Operating Income-15.6 M-14.8 M
Income Before Tax-14.7 M-13.9 M
Total Other Income Expense Net924 K970.2 K
Net Loss-14.7 M-13.9 M
Income Tax Expense155.1 K162.9 K
Net Interest Income924 K970.2 K
Interest Income14.9 K15.7 K
Net Loss-14.7 M-15.4 M
Net Loss-15.3 M-16 M
Change To Netincome288.9 K274.5 K
Net Loss(0.32)(0.34)
Income Quality 0.85  0.67 
Net Income Per E B T 0.91  0.81 

Icecure Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Icecure Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Icecure Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Icecure Medical's important profitability drivers and their relationship over time.

Use Icecure Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Icecure Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icecure Medical will appreciate offsetting losses from the drop in the long position's value.

Icecure Medical Pair Trading

Icecure Medical Pair Trading Analysis

The ability to find closely correlated positions to Icecure Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Icecure Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Icecure Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Icecure Medical to buy it.
The correlation of Icecure Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Icecure Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Icecure Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Icecure Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Icecure Medical position

In addition to having Icecure Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alcohol Thematic Idea Now

Alcohol
Alcohol Theme
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out Risk vs Return Analysis.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
To fully project Icecure Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Icecure Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Icecure Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Icecure Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Icecure Medical investors may work on each financial statement separately, they are all related. The changes in Icecure Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Icecure Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.